Compugen (Israel) Performance

CGEN Stock  ILA 566.20  28.80  4.84%   
Compugen has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.0612, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Compugen are expected to decrease at a much lower rate. During the bear market, Compugen is likely to outperform the market. Compugen right now shows a risk of 3.64%. Please confirm Compugen coefficient of variation, jensen alpha, sortino ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if Compugen will be following its price patterns.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Compugen are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Compugen may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Begin Period Cash Flow7.8 M
Total Cashflows From Investing Activities6.6 M
  

Compugen Relative Risk vs. Return Landscape

If you would invest  55,500  in Compugen on November 4, 2025 and sell it today you would earn a total of  1,120  from holding Compugen or generate 2.02% return on investment over 90 days. Compugen is generating 0.1007% of daily returns and assumes 3.6396% volatility on return distribution over the 90 days horizon. Simply put, 32% of stocks are less volatile than Compugen, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Compugen is expected to generate 4.83 times more return on investment than the market. However, the company is 4.83 times more volatile than its market benchmark. It trades about 0.03 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of risk.

Compugen Target Price Odds to finish over Current Price

The tendency of Compugen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 566.20 90 days 566.20 
about 40.75
Based on a normal probability distribution, the odds of Compugen to move above the current price in 90 days from now is about 40.75 (This Compugen probability density function shows the probability of Compugen Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Compugen has a beta of -0.0612 suggesting as returns on the benchmark increase, returns on holding Compugen are expected to decrease at a much lower rate. During a bear market, however, Compugen is likely to outperform the market. Additionally Compugen has an alpha of 0.0935, implying that it can generate a 0.0935 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Compugen Price Density   
       Price  

Predictive Modules for Compugen

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Compugen. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
562.56566.20569.84
Details
Intrinsic
Valuation
LowRealHigh
489.40493.04622.82
Details
Naive
Forecast
LowNextHigh
466.40470.04473.68
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
429.40597.12764.84
Details

Compugen Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Compugen is not an exception. The market had few large corrections towards the Compugen's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Compugen, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Compugen within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.09
β
Beta against Dow Jones-0.06
σ
Overall volatility
71.90
Ir
Information ratio 0.01

Compugen Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Compugen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Compugen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Compugen had very high historical volatility over the last 90 days
The company reported the revenue of 6 M. Net Loss for the year was (34.2 M) with profit before overhead, payroll, taxes, and interest of 5.32 M.
Compugen has accumulated about 110.41 M in cash with (22.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32.

Compugen Fundamentals Growth

Compugen Stock prices reflect investors' perceptions of the future prospects and financial health of Compugen, and Compugen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Compugen Stock performance.

About Compugen Performance

By analyzing Compugen's fundamental ratios, stakeholders can gain valuable insights into Compugen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Compugen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Compugen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 68 people.

Things to note about Compugen performance evaluation

Checking the ongoing alerts about Compugen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Compugen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Compugen had very high historical volatility over the last 90 days
The company reported the revenue of 6 M. Net Loss for the year was (34.2 M) with profit before overhead, payroll, taxes, and interest of 5.32 M.
Compugen has accumulated about 110.41 M in cash with (22.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32.
Evaluating Compugen's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Compugen's stock performance include:
  • Analyzing Compugen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Compugen's stock is overvalued or undervalued compared to its peers.
  • Examining Compugen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Compugen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Compugen's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Compugen's stock. These opinions can provide insight into Compugen's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Compugen's stock performance is not an exact science, and many factors can impact Compugen's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Compugen Stock analysis

When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets